-
Advocates, Some AGs Wary of Purdue Pharma Bankruptcy Plan
OxyContin maker Purdue Pharma has a $10 billion plan to transform into a new company dedicated to fighting the opioid crisis, but its not a done deal yet
-
Family Behind OxyContin Attests to Its Role in Opioid Crisis
Two members of the Sackler family that owns OxyContin maker Purdue Pharma have acknowledged the drug had a role in the opioid epidemic
-
Purdue Pharma Pleads Guilty for Role in Opioid Crisis
Purdue Pharma, the manufacturer of the painkiller Oxycontin, pleaded guilty to charges for its role in the opioid crisis.
-
OxyContin Maker Purdue Pharma Pleads Guilty in Criminal Case
Purdue Pharma says its guilty plea over its role in the opioid crisis is “an essential step to preserve billions of dollars” for the settlement it is pursuing in bankruptcy court
-
Bankruptcy Judge OKs Federal Settlement With Purdue Pharma
A bankruptcy judge has given his approval to OxyContin maker Purdue Pharma’s $8 billion settlement with the U.S. Department of Justice.
-
Purdue Pharma Agrees to Plead Guilty Over Aggressive OxyContin Marketing
The Department of Justice announced Wednesday that Purdue Pharma agreed to plead guilty to criminal charges for their marketing of OxyContin.
-
OxyContin Maker Purdue Pharma to Plead to 3 Criminal Charges for Role in Opioid Crisis
The Justice Department says Purdue Pharma, the company that makes OxyContin, will plead guilty to three federal criminal charges as part of a settlement of more than $8 billion. OxyContin is the powerful prescription painkiller that experts say helped touch off an opioid epidemic. The charges include conspiracy to defraud the United States and violating federal anti-kickback laws. The deal...
-
Jonathan Sackler, Co-Owner of OxyContin Maker Purdue Pharma, Dies
Jonathan Sackler, one of the co-owners of OxyContin maker Purdue Pharma, has died at 65
-
Oxycontin Maker Purdue Pharma Starts Ad Campaign for Claims
OxyContin maker Purdue Pharma launched an ad campaign Monday to tell people harmed by their powerful prescription opioid where they can file claims against the company. The $23.8 million campaign is part of Purdue’s bankruptcy proceedings as it tries to resolve close to 3,000 lawsuits over its role in the opioid crisis. Notifying people who might have claims against a…
-
Opioid Victims Can Begin Filing Claims Against Purdue Pharma
The federal judge overseeing the bankruptcy case of OxyContin maker Purdue Pharma set a June 30 deadline to file claims against the company
-
Tufts University Severs Ties With Family Behind OxyContin
Tufts University is cutting ties with the billionaire family that owns OxyContin maker Purdue Pharma, saying it will strip the Sackler name from its campus and accept no further donations amid concerns over the family’s role in the opioid crisis. University officials announced the decision Thursday, ending a relationship that has spanned nearly four decades and brought $15 million to…
-
Oklahoma Judge Reduces J&J Order in Opioid Lawsuit by $107M
An Oklahoma judge who last summer ordered consumer products giant Johnson & Johnson to pay $572 million to help address the state’s opioid crisis on Friday reduced that amount in his final order in the case by $107 million because of his miscalculation. District Judge Thad Balkman’s latest order directs the company to pay the state $465 million. In it,...
-
Victims, Families Gain Key Role in Purdue Bankruptcy Case
Victims of opioid addiction weren’t in the room when OxyContin maker Purdue Pharma persuaded half the state attorneys general to settle claims over the company’s role in the nationwide overdose epidemic. Now that Purdue is in federal bankruptcy court, four people whose lives were touched by addiction have important seats at the table — and could force fundamental changes to...
-
Purdue Opioid Deal Blasted as Records Show $13B to Sacklers
Attorneys general representing nearly half the states and lawyers for more than 500 local governments on Friday blasted the terms of Purdue Pharma’s offer to settle thousands of lawsuits over the nation’s opioid crisis in court filings that also said the company had funneled up to $13 billion to its controlling family. Their legal filings said the tentative deal does...
-
NH Joins States Suing Family Over Purdue Pharma
New Hampshire has filed a lawsuit against the family that owns OxyContin maker Purdue Pharma as part of an effort to address the opioid epidemic. Including New Hampshire, at least six states have sued members of the Sackler family in September. New Hampshire, which was among the states that rejected a Purdue/Sackler settlement proposal, also had filed a separate complaint...
-
Mass. AG Maura Healey Vows to Continue Fighting Purdue Pharma Following Bankruptcy Filing
Massachusetts Attorney General Maura Healey vowed Monday to “aggressively” fight to make sure Purdue Pharma remains out of business, hours after the OxyContin maker filed for bankruptcy.
-
The Rise and Fall of an Eagle Scout's Deadly Fentanyl Empire
The photo that flashed onto the courtroom screen showed a young man dead on his bedroom floor, bare feet poking from the cuffs of his rolled-up jeans. Lurking on a trash can at the edge of the picture was what prosecutors said delivered this death: an ordinary, U.S. Postal Service envelope. It had arrived with 10 round, blue pills inside,...
-
Tentative Opioids Settlement Falls Short of Nationwide Deal
A tentative settlement announced Wednesday over the role Purdue Pharma played in the nation’s opioid addiction crisis falls short of the far-reaching national settlement the OxyContin maker had been seeking for months, with litigation sure to continue against the company and the family that owns it. The agreement with about half the states and attorneys representing roughly 2,000 local governments...
-
OxyContin Maker Agrees to Tentative Settlement: Attorneys
Attorneys for some 2,000 local governments say they have agreed to a tentative settlement with OxyContin maker Purdue Pharma over the toll of the nation’s opioid crisis.
-
Purdue University: School Has No Connection to Purdue Pharma
Purdue University in Indiana wants the public to know that it has no connection to a Connecticut-based company blamed for helping drive the nation’s opioid crisis.